Replimune Group, Inc.
US ˙ NasdaqGS ˙ US76029N1063

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Jason P Rhodes. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Jason P Rhodes reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
Director 1,136,810
US:GBIO / Generation Bio Co. Director 0
US:REPL / Replimune Group, Inc. Director 16,500
US:GMTX / Gemini Therapeutics Inc Director, 10% Owner 17,245
US:EPZM / Epizyme Inc President, CFO and Treasurer 149,459
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Jason P Rhodes. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas REPL / Replimune Group, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em REPL / Replimune Group, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2019-11-18 REPL Rhodes Jason P 1,100,000 13.6100 1,100,000 13.6100 14,971,000 365 48.9100 38,830,000 259.37

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

REPL / Replimune Group, Inc. Insider Trades
Vendas Internas REPL / Replimune Group, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em REPL / Replimune Group, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

REPL / Replimune Group, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Jason P Rhodes conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2026-05-06 2026-05-06 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -17,244 1,136,810 -1.49 18.18 -313,496 20,667,206
2026-05-06 2026-05-06 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -428 7,962 -5.10 18.18 -7,781 144,749
2026-05-06 2026-05-06 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -43,621 4,883,494 -0.89 18.18 -793,030 88,781,921
2026-05-06 2026-05-06 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -21,926 1,549,288 -1.40 18.18 -398,615 28,166,056
2026-05-06 2026-05-05 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2,403 1,154,054 -0.21 18.03 -43,326 20,807,594
2026-05-06 2026-05-05 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -60 8,390 -0.71 18.03 -1,082 151,272
2026-05-06 2026-05-05 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -6,081 4,927,115 -0.12 18.03 -109,640 88,835,883
2026-05-06 2026-05-05 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -3,056 1,571,214 -0.19 18.03 -55,100 28,328,988
2026-05-06 2026-05-04 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2,466 1,156,457 -0.21 18.00 -44,388 20,816,226
2026-05-06 2026-05-04 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -61 8,450 -0.72 18.00 -1,098 152,100
2026-05-06 2026-05-04 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -6,241 4,933,196 -0.13 18.00 -112,338 88,797,528
2026-05-06 2026-05-04 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -3,136 1,574,270 -0.20 18.00 -56,448 28,336,860
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -21 1,158,923 0.00 19.00 -399 22,019,537
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -1 8,511 -0.01 19.00 -19 161,709
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -52 4,939,437 0.00 19.00 -988 93,849,303
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -26 1,577,406 0.00 19.00 -494 29,970,714
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -47,082 1,158,944 -3.90 18.38 -865,367 21,301,391
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -1,170 8,512 -12.08 18.38 -21,505 156,451
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -119,115 4,939,489 -2.35 18.38 -2,189,334 90,787,808
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -59,870 1,577,432 -3.66 18.38 -1,100,411 28,993,200
2026-04-27 2026-04-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -35,947 1,206,026 -2.89 18.15 -652,438 21,889,372
2026-04-27 2026-04-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -894 9,682 -8.45 18.15 -16,226 175,728
2026-04-27 2026-04-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -90,943 5,058,604 -1.77 18.15 -1,650,615 91,813,663
2026-04-27 2026-04-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -45,709 1,637,302 -2.72 18.15 -829,618 29,717,031
2026-04-27 2026-04-24 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -28,583 1,241,973 -2.25 18.48 -528,214 22,951,661
2026-04-27 2026-04-24 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -710 10,576 -6.29 18.48 -13,121 195,444
2026-04-27 2026-04-24 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -72,310 5,149,547 -1.38 18.48 -1,336,289 95,163,629
2026-04-27 2026-04-24 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -36,345 1,683,011 -2.11 18.48 -671,656 31,102,043
2026-04-27 2026-04-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -15,148 1,270,556 -1.18 19.19 -290,690 24,381,970
2026-04-27 2026-04-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -377 11,286 -3.23 19.19 -7,235 216,578
2026-04-27 2026-04-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -38,322 5,221,857 -0.73 19.19 -735,399 100,207,436
2026-04-27 2026-04-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -19,261 1,719,356 -1.11 19.19 -369,619 32,994,442
2026-04-22 2026-04-22 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -59,663 1,285,704 -4.43 19.68 -1,174,168 25,302,655
2026-04-22 2026-04-22 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -1,485 11,663 -11.29 19.68 -29,225 229,528
2026-04-22 2026-04-22 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -150,942 5,260,179 -2.79 19.68 -2,970,539 103,520,323
2026-04-22 2026-04-22 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -75,866 1,738,617 -4.18 19.68 -1,493,043 34,215,983
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -605 1,345,367 -0.04 20.05 -12,130 26,974,608
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -15 13,148 -0.11 20.05 -301 263,617
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -1,530 5,411,121 -0.03 20.05 -30,676 108,492,976
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -769 1,814,483 -0.04 20.05 -15,418 36,380,384
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -56,228 1,345,972 -4.01 19.51 -1,097,008 26,259,914
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -1,398 13,163 -9.60 19.51 -27,275 256,810
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -142,253 5,412,651 -2.56 19.51 -2,775,356 105,600,821
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -71,499 1,815,252 -3.79 19.51 -1,394,945 35,415,567
2026-04-22 2026-04-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -56,368 1,402,200 -3.86 20.06 -1,130,742 28,128,132
2026-04-22 2026-04-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -1,401 14,561 -8.78 20.06 -28,104 292,094
2026-04-22 2026-04-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -142,604 5,554,904 -2.50 20.06 -2,860,636 111,431,374
2026-04-22 2026-04-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -71,676 1,886,751 -3.66 20.06 -1,437,821 37,848,225
2026-02-09 2026-02-09 4 GBIO Generation Bio Co.
Common Stock
U - Other -60 0 -100.00
2026-02-09 2026-02-09 4 GBIO Generation Bio Co.
Common Stock
U - Other -116,693 0 -100.00
2026-02-09 2026-02-09 4 GBIO Generation Bio Co.
Common Stock
U - Other -711,193 0 -100.00
2025-01-29 2025-01-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
A - Award 1,111,111 1,958,427 131.13 13.50 14,999,998 26,438,764
2024-11-18 2024-11-14 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale -72 847,316 -0.01 33.10 -2,383 28,046,160
2024-11-18 2024-11-14 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale -123 1,458,568 -0.01 33.10 -4,071 48,278,601
2024-11-18 2024-11-14 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale -4 15,962 -0.03 33.10 -132 528,342
2024-11-18 2024-11-14 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale -583 5,697,508 -0.01 33.10 -19,297 188,587,515
2024-03-05 2024-03-01 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -17,099 847,388 -1.98 30.05 -513,825 25,464,009
2024-03-05 2024-03-01 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -29,435 1,458,691 -1.98 30.05 -884,522 43,833,665
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -210 864,487 -0.02 25.25 -5,302 21,828,297
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -13,109 864,697 -1.49 24.83 -325,496 21,470,427
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -360 1,488,126 -0.02 25.25 -9,090 37,575,182
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -22,567 1,488,486 -1.49 24.83 -560,339 36,959,107
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2,430 5,698,091 -0.04 25.25 -61,358 143,876,798
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -152,244 5,700,521 -2.60 24.83 -3,780,219 141,543,936
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2,216 877,806 -0.25 24.68 -54,691 21,664,252
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -23,505 880,022 -2.60 24.38 -573,052 21,454,936
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -3,821 1,511,053 -0.25 24.68 -94,302 37,292,788
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -40,455 1,514,874 -2.60 24.38 -986,293 36,932,628
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -25,779 5,852,765 -0.44 24.68 -636,226 144,446,240
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -272,923 5,878,544 -4.44 24.38 -6,653,863 143,318,903
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -5,580 903,527 -0.61 23.98 -133,808 21,666,577
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -11,736 909,107 -1.27 23.59 -276,852 21,445,834
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -9,603 1,555,329 -0.61 23.98 -230,280 37,296,789
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -20,205 1,564,932 -1.27 23.59 -476,636 36,916,746
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -64,783 6,151,467 -1.04 23.98 -1,553,496 147,512,179
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -136,312 6,216,250 -2.15 23.59 -3,215,600 146,641,338
2024-02-23 2024-02-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -13,738 920,843 -1.47 22.70 -311,853 20,903,136
2024-02-23 2024-02-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -23,648 1,585,137 -1.47 22.70 -536,810 35,982,610
2024-02-23 2024-02-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -159,542 6,352,562 -2.45 22.70 -3,621,603 144,203,157
2024-02-23 2024-02-22 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -119,360 6,512,104 -1.80 22.66 -2,704,698 147,564,277
2024-02-23 2024-02-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -35,164 6,631,464 -0.53 23.14 -813,695 153,452,077
2024-02-23 2024-02-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -149,337 6,666,628 -2.19 22.44 -3,351,122 149,599,132
2024-02-20 2024-02-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -3,510 6,815,965 -0.05 23.40 -82,134 159,493,581
2024-02-20 2024-02-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -166,029 6,819,475 -2.38 22.71 -3,770,519 154,870,277
2024-02-20 2024-02-16 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -162,707 6,985,504 -2.28 23.14 -3,765,040 161,644,563
2024-02-20 2024-02-15 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2,113 7,148,211 -0.03 24.45 -51,663 174,773,759
2024-02-20 2024-02-15 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -175,793 7,150,324 -2.40 23.88 -4,197,937 170,749,737
2022-12-14 2022-12-12 4 DYN Dyne Therapeutics, Inc.
Common Stock
P - Purchase 934,581 934,581 10.70 10,000,017 10,000,017
2022-04-05 2022-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 16,500 16,500
2021-10-06 2021-10-04 4 GMTX Gemini Therapeutics, Inc. /DE
Stock Option (Right to Buy)
A - Award 17,245 17,245
2021-09-29 2021-09-29 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -30 608 -4.70 24.59 -738 14,951
2021-09-29 2021-09-29 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -16,556 0 -100.00 24.59 -407,112
2021-09-29 2021-09-28 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -24 638 -3.63 25.24 -606 16,103
2021-09-29 2021-09-28 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -13,089 16,556 -44.15 25.24 -330,366 417,873
2021-09-29 2021-09-27 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -95 662 -12.55 25.70 -2,442 17,013
2021-09-29 2021-09-27 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -51,294 29,645 -63.37 25.70 -1,318,256 761,876
2021-09-24 2021-09-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -54 757 -6.66 25.84 -1,395 19,560
2021-09-24 2021-09-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -28,862 80,939 -26.29 25.84 -745,765 2,091,383
2021-09-24 2021-09-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -140 811 -14.72 26.13 -3,659 21,194
2021-09-24 2021-09-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -1 109,801 0.00 26.55 -27 2,915,217
2021-09-24 2021-09-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -75,324 109,802 -40.69 26.13 -1,968,442 2,869,456
2021-09-24 2021-09-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -57 951 -5.65 25.89 -1,476 24,622
2021-09-24 2021-09-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -30,560 185,126 -14.17 25.89 -791,229 4,793,097
2021-06-28 2021-06-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -8 608 -1.30 26.39 -211 16,045
2021-06-28 2021-06-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -50 616 -7.51 25.77 -1,288 15,874
2021-06-28 2021-06-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -4,092 0 -100.00 26.39 -107,988
2021-06-28 2021-06-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -26,858 4,092 -86.78 25.77 -692,131 105,451
2021-06-23 2021-06-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -53 666 -7.37 25.69 -1,362 17,110
2021-06-23 2021-06-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -63 719 -8.06 25.08 -1,580 18,033
2021-06-23 2021-06-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -28,331 30,950 -47.79 25.69 -727,823 795,106
2021-06-23 2021-06-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -34,162 59,281 -36.56 25.08 -856,783 1,486,767
2021-06-23 2021-06-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -47 782 -5.67 25.20 -1,184 19,706
2021-06-23 2021-06-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -61 829 -6.85 24.76 -1,510 20,526
2021-06-23 2021-06-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -25,208 93,443 -21.25 25.20 -635,242 2,354,764
2021-06-23 2021-06-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -33,261 118,651 -21.89 24.76 -823,542 2,937,799
2021-06-23 2021-06-21 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -7 890 -0.78 25.12 -176 22,357
2021-06-23 2021-06-21 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -111 897 -11.01 24.82 -2,755 22,264
2021-06-23 2021-06-21 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -3,796 151,912 -2.44 25.12 -95,356 3,816,029
2021-06-23 2021-06-21 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -59,978 155,708 -27.81 24.82 -1,488,654 3,864,673
2021-06-11 2021-06-09 4 GBIO Generation Bio Co.
Stock Option (right to buy)
A - Award 15,000 15,000
2021-05-27 2021-05-26 4 DYN Dyne Therapeutics, Inc.
Stock Option (right to buy)
A - Award 19,596 19,596
2021-04-14 2021-04-14 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -12,874 0 -100.00 26.78 -344,766
2021-04-14 2021-04-14 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -10,539 12,874 -45.01 26.40 -278,230 339,874
2021-04-14 2021-04-13 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -7,354 23,413 -23.90 25.53 -187,748 597,734
2021-04-14 2021-04-13 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -35,791 30,767 -53.77 25.09 -897,996 771,944
2021-04-14 2021-04-12 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -10,771 66,558 -13.93 26.61 -286,616 1,771,108
2021-04-14 2021-04-12 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -63,353 77,329 -45.03 26.07 -1,651,613 2,015,967
2021-04-09 2021-04-09 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -2,132 140,682 -1.49 28.35 -60,442 3,988,335
2021-04-09 2021-04-09 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -41,549 142,814 -22.54 27.57 -1,145,506 3,937,382
2021-04-09 2021-04-08 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -3,191 184,363 -1.70 28.90 -92,220 5,328,091
2021-04-09 2021-04-08 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -40,359 187,554 -17.71 28.47 -1,149,021 5,339,662
2021-04-09 2021-04-07 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -1,894 227,913 -0.82 29.19 -55,286 6,652,780
2021-04-09 2021-04-07 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -37,970 229,807 -14.18 28.48 -1,081,386 6,544,903
2021-04-05 2021-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 16,500 16,500
2021-02-11 3 GMTX Gemini Therapeutics, Inc. /DE
Common Stock
4,015,045
2021-02-11 3 GMTX Gemini Therapeutics, Inc. /DE
Common Stock
729,320
2021-02-11 3 GMTX Gemini Therapeutics, Inc. /DE
Common Stock
510,000
2021-01-28 2021-01-26 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -5,558 946,000 -0.58 46.14 -256,446 43,648,440
2020-12-22 2020-12-18 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -265 19,285 -1.36 41.95 -11,117 809,006
2020-12-22 2020-12-18 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1,042 951,558 -0.11 41.95 -43,712 39,917,858
2020-12-22 2020-12-18 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -3,012 2,263,627 -0.13 41.95 -126,353 94,959,153
2020-12-17 2020-12-17 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -697 19,550 -3.44 42.00 -29,274 821,100
2020-12-17 2020-12-17 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2,785 952,600 -0.29 42.00 -116,970 40,009,200
2020-12-17 2020-12-17 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -8,053 2,266,639 -0.35 42.00 -338,226 95,198,838
2020-12-17 2020-12-16 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -766 20,247 -3.65 42.13 -32,272 853,006
2020-12-17 2020-12-16 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -3,060 955,385 -0.32 42.13 -128,918 40,250,370
2020-12-17 2020-12-16 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -8,849 2,274,692 -0.39 42.13 -372,808 95,832,774
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -6 21,013 -0.03 44.08 -264 926,253
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -30 21,019 -0.14 43.12 -1,294 906,339
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2,432 21,049 -10.36 42.40 -103,117 892,478
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -24 958,445 0.00 44.08 -1,058 42,248,256
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -120 958,469 -0.01 43.12 -5,174 41,329,183
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -9,710 958,589 -1.00 42.40 -411,704 40,644,174
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -70 2,283,541 0.00 44.08 -3,086 100,658,487
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -349 2,283,611 -0.02 43.12 -15,049 98,469,306
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -28,078 2,283,960 -1.21 42.40 -1,190,507 96,839,904
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -181 23,481 -0.76 44.06 -7,975 1,034,573
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1,855 23,662 -7.27 43.54 -80,767 1,030,243
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -240 25,517 -0.93 42.69 -10,246 1,089,321
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -722 968,299 -0.07 44.06 -31,811 42,663,254
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -7,409 969,021 -0.76 43.54 -322,588 42,191,174
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -961 976,430 -0.10 42.69 -41,025 41,683,797
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2,087 2,312,038 -0.09 44.06 -91,953 101,868,394
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -21,428 2,314,125 -0.92 43.54 -932,975 100,757,002
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2,776 2,335,553 -0.12 42.69 -118,507 99,704,758
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -205 25,757 -0.79 43.92 -9,004 1,131,247
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1,707 25,962 -6.17 43.32 -73,947 1,124,674
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -821 977,391 -0.08 43.92 -36,058 42,927,013
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -6,817 978,212 -0.69 43.32 -295,312 42,376,144
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2,374 2,338,329 -0.10 43.92 -104,266 102,699,410
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -19,712 2,340,703 -0.84 43.32 -853,924 101,399,254
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -230 27,669 -0.82 44.35 -10,200 1,227,120
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -750 27,899 -2.62 43.48 -32,610 1,213,049
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1,099 28,649 -3.69 42.68 -46,905 1,222,739
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -917 985,029 -0.09 44.35 -40,669 43,686,036
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2,996 985,946 -0.30 43.48 -130,266 42,868,932
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -4,389 988,942 -0.44 42.68 -187,323 42,208,045
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2,653 2,360,415 -0.11 44.35 -117,661 104,684,405
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -8,666 2,363,068 -0.37 43.48 -376,798 102,746,197
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -12,691 2,371,734 -0.53 42.68 -541,652 101,225,607
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -151 29,748 -0.51 45.32 -6,843 1,348,179
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -635 29,899 -2.08 44.69 -28,378 1,336,186
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1,549 30,534 -4.83 43.36 -67,165 1,323,954
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -151 32,083 -0.47 42.51 -6,419 1,363,848
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -100 993,331 -0.01 46.47 -4,647 46,160,092
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -604 993,431 -0.06 45.32 -27,373 45,022,293
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2,535 994,035 -0.25 44.69 -113,289 44,423,424
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -6,183 996,570 -0.62 43.36 -268,095 43,211,275
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -603 1,002,753 -0.06 42.51 -25,634 42,627,030
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1,747 2,384,425 -0.07 45.32 -79,174 108,062,141
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -7,330 2,386,172 -0.31 44.69 -327,578 106,638,027
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -17,883 2,393,502 -0.74 43.36 -775,407 103,782,247
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1,745 2,411,385 -0.07 42.51 -74,180 102,507,976
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2,869 32,234 -8.17 46.94 -134,671 1,513,064
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -606 35,103 -1.70 46.02 -27,888 1,615,440
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -45,027 1,003,356 -4.29 46.89 -2,111,316 47,047,363
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -19,620 1,048,383 -1.84 46.14 -905,267 48,372,392
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -33,133 2,413,130 -1.35 46.94 -1,555,263 113,272,322
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -7,001 2,446,263 -0.29 46.02 -322,186 112,577,023
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -106 35,709 -0.30 46.91 -4,972 1,675,109
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2,007 35,815 -5.31 45.97 -92,262 1,646,416
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -748 37,822 -1.94 45.46 -34,004 1,719,388
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2,322 1,068,003 -0.22 46.93 -108,971 50,121,381
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -26,713 1,070,325 -2.44 46.06 -1,230,401 49,299,170
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2,962 1,097,038 -0.27 45.45 -134,623 49,860,377
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1,222 2,453,264 -0.05 46.91 -57,324 115,082,614
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -23,174 2,454,486 -0.94 45.97 -1,065,309 112,832,721
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -8,636 2,477,660 -0.35 45.46 -392,593 112,634,424
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -5,336,179 0 -100.00
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -20,000,000 0 -100.00
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
C - Conversion 1,608,785 1,608,785
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
C - Conversion 6,029,726 8,140,130 285.71
2020-09-16 3 DYN Dyne Therapeutics, Inc.
Common Stock
2,110,404
2020-06-18 2020-06-16 4 GBIO Generation Bio Co.
Series C Preferred Stock
C - Conversion -2,683 0 -100.00
2020-06-18 2020-06-16 4 GBIO Generation Bio Co.
Series A Preferred Stock
C - Conversion -15,051,020 0 -100.00
2020-06-18 2020-06-16 4 GBIO Generation Bio Co.
Common Stock
C - Conversion 10,040,032 12,630,758 387.54
2020-06-15 2020-06-11 4 GBIO Generation Bio Co.
Stock Option (right to buy)
A - Award 52,000 52,000
2020-06-11 3 GBIO Generation Bio Co.
Common Stock
5,181,452
2020-06-11 3 GBIO Generation Bio Co.
Common Stock
5,181,452
2020-06-11 3 GBIO Generation Bio Co.
Common Stock
5,181,452
2020-04-02 2020-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 16,500 16,500
2019-11-20 2019-11-18 4 REPL Replimune Group, Inc.
Common Stock
P - Purchase 1,100,000 1,100,000 13.61 14,971,000 14,971,000
2019-04-03 2019-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 13,500 13,500
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 13,500 13,500
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Series B Convertible Preferred Stock
C - Conversion -1,013,547 0 -100.00
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Series A Convertible Preferred Stock
C - Conversion -3,439,839 0 -100.00
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Common Stock
C - Conversion 1,013,547 4,453,386 29.46
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Common Stock
C - Conversion 3,439,839 3,439,839
2014-09-24 2014-09-22 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise -44,000 149,459 -22.74
2014-09-24 2014-09-22 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise 44,000 138,000 46.81 0.51 22,440 70,380
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -36,000 34,819 -50.83
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,000 188,833 -3.08
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -5,972 94,000 -5.97 33.89 -202,392 3,185,669
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -24,028 99,972 -19.38 33.37 -801,771 3,335,886
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 36,000 124,000 40.91 0.60 21,600 74,400
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 6,000 88,000 7.32 3.54 21,240 311,520
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -34,000 70,819 -32.44
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -8,000 194,833 -3.94
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -18,400 82,000 -18.33 30.05 -552,898 2,464,002
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -11,600 100,400 -10.36 29.26 -339,426 2,937,794
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 34,000 112,000 43.59 0.60 20,400 67,200
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 8,000 78,000 11.43 3.54 28,320 276,120
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -32,000 193,459 -14.19
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -4,000 104,819 -3.68
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,000 202,833 -2.87
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -6,446 70,000 -8.43 33.55 -216,258 2,348,444
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -23,554 76,446 -23.55 32.52 -765,903 2,485,787
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 32,000 100,000 47.06 0.51 16,320 51,000
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 4,000 68,000 6.25 0.60 2,400 40,800
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 6,000 64,000 10.34 3.54 21,240 226,560
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -27,000 225,459 -10.69
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -15,000 208,833 -6.70
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -1,264 58,000 -2.13 23.36 -29,529 1,354,967
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -28,736 59,264 -32.65 22.14 -636,341 1,312,366
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 27,000 88,000 44.26 0.51 13,770 44,880
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 15,000 61,000 32.61 3.54 53,100 215,940
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -5,000 252,459 -1.94
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -37,000 223,833 -14.19
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -30,000 46,000 -39.47 21.53 -645,840 990,288
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 5,000 76,000 7.04 0.51 2,550 38,760
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 37,000 71,000 108.82 3.54 130,980 251,340
2014-04-08 2014-04-07 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -35,000 257,459 -11.97
2014-04-08 2014-04-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -25,000 34,000 -42.37 20.05 -501,190 681,618
2014-04-08 2014-04-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 35,000 59,000 145.83 0.51 17,850 30,090
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise -20,000 292,459 -6.40
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise -50,000 260,833 -16.09
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale -50,000 24,000 -67.57 29.25 -1,462,500 702,000
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise 20,000 74,000 37.04 0.51 10,200 37,740
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise 50,000 54,000 1,250.00 3.54 177,000 191,160
2014-01-30 2014-01-28 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 27,406 27,406
2014-01-06 2014-01-06 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -14,000 312,459 -4.29
2014-01-06 2014-01-06 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -10,000 4,000 -71.43 20.19 -201,874 80,750
2014-01-06 2014-01-06 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 14,000 14,000 0.51 7,140 7,140
2013-07-03 2013-07-01 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 50,000 50,000
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)